Home About us Articles Multimedia Search Instructions Login 
IF 2017: 1.596 (® Clarivate Analytics)
Total Cites: 7606
Q2 in Medicine, General & Internal
Follow Us
Follow Us
  • Users Online: 2173
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure

Huang Dong-Hui, Sun Hao, Shi Jing-Pu

Year : 2016| Volume: 129| Issue : 5 | Page no: 570-577

   This article has been cited by
1 Personalized medicine in inflammatory cardiomyopathy
Balram Neupane,Qifeng Zhou,Meinrad Gawaz,Michael Gramlich
Personalized Medicine. 2018; 15(2): 127
[Pubmed]  [Google Scholar] [DOI]
2 Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study
Vanessa Pfetsch,Veronika Sanin,Andrea Jaensch,Dhayana Dallmeier,Ute Mons,Hermann Brenner,Wolfgang Koenig,Dietrich Rothenbacher
Cardiovascular Drugs and Therapy. 2017;
[Pubmed]  [Google Scholar] [DOI]
3 ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure
Nadia Aspromonte,Michele Massimo Gulizia,Aldo Clerico,Giuseppe Di Tano,Michele Emdin,Mauro Feola,Massimo Iacoviello,Roberto Latini,Andrea Mortara,Roberto Valle,Gianfranco Misuraca,Claudio Passino,Serge Masson,Alberto Aimo,Marcello Ciaccio,Marco Migliardi
European Heart Journal Supplements. 2017; 19(suppl_D): D102
[Pubmed]  [Google Scholar] [DOI]
4 Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction
Anan Huang,Xin Qi,Wenguang Hou,Yanfang Qi,Na Zhao,Keqaing Liu
Acta Cardiologica. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]


Read this article